A phase III,observer-blind,randomized, placebo-controlled study of the efficacy,safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia |
| |
摘 要: |
|
收稿时间: | 2021-05-21 |
本文献已被 ScienceDirect 等数据库收录! |
|